# The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging

> **NCT06359054** · NA · COMPLETED · sponsor: **Celal Bayar University** · enrollment: 16 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** 18F FDG PET/CT
- **DIAGNOSTIC_TEST:** 68Ga DOTATATE PET/CT

## Key facts

- **NCT ID:** NCT06359054
- **Lead sponsor:** Celal Bayar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-11
- **Primary completion:** 2023-05-15
- **Final completion:** 2023-09-15
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06359054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06359054, "The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06359054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*